The present study aims to report a-20-year old girl with systemic lupus erythematosus (SLE) who developed myocardial infarction (MI) and also aims to review acute myocardial infarction (AMI) in young SLE cases (≤35 years) reported in the literature. We conducted a comprehensive review of the English literature from 1975 to 2006 to analyse data on MI in SLE patients who had developed AMI either at 35 or earlier. In 32 English articles, we identified 49 SLE patients, plus our case, with AMI. They consist of 41 female and nine male patients, their mean age being 24 ± 6.4 years (range of 5—35). Disease duration varied between 0 and 13 years. The lag time between the onset of the SLE manifestations and development of AMI was 7.7 ± 5.4 year (range of 1 month to 20.5 years). We divided the patients into three subgroups according to their coronary involvement type (Group I: normal coronary artery or coronary thrombosis (n = 16); Group II: coronary aneurysm/arteritis (n = 12); Group III: coronary atherosclerosis (n = 22)). The lag time between the onset of the SLE manifestations and development of MI in the subgroups showed variations: Group I < Group II < Group III. Both prevalence of renal involvement and steroid therapy were higher in patients with coronary atherosclerosis than were in Group I. There were one or more risk factors for atherosclerosis in 39 SLE patients. AMI in young SLE patients may be seen, albeit rare. We suggest that clinicians should have a low threshold for cardiac evaluation in patients with SLE. Also, traditional risk factors could be managed through preventive measures. Lupus (2007) 16, 289—297.
Manzi S., Meilahn EN, Rairie JE et al. Age specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol1997; 145: 408—415
2.
Meller J., Conde CA, Deppisch LM et al. Myocardial infarction due to coronary atherosclerosis in three young adults with systemic lupus erythematosus. Am J Cardiol1975; 35: 309—314.
3.
Homcy CJ, Liberthson RR, Fallon JT et al. Ischemic heart disease in systemic lupus erythematosus in the young patient: report of six cases. Am J Cardiol1982; 49: 478—484.
4.
Ishikawa S., Segar WE, Gilbert EF et al. Myocardial infarct in a child with systemic lupus erythematosus . Am J Dis Child1978; 132: 696—699.
5.
Coenen JL, Nikkels REA patient with probable systemic lupus erythematosus, lupus anticoagulant and myocardial infarction. Neth J Med1989 ; 35: 253—259.
6.
Takatsu Y., Hattori R., Sakaguchi K. et al. Acute myocardial infarction associated with systemic lupus erythematosus documented by coronary arteriograms. Chest1985; 88: 147—149.
7.
Maaravi Y., Raz E., Gilon D. et al. Cerebrovascular accident and myocardial infarction associated with anticardiolipin antibodies in a young woman with systemic lupus erythematosus . Ann Rheum Dis1989; 48: 853—855.
8.
Rangel A., Lavalle C., Chavez E. et al. Myocardial infarction in patients with systemic lupus erythematosus with normal findings from coronary arteriography and without coronary vasculitis — case reports. Angiology1999; 50: 245—253.
9.
Miller DJ, Maisch SA, Perez MD et al. Fatal myocardial infarction in an 8-year-old girl with systemic lupus erythematosus, Raynaud's phenomenon, and secondary antiphospholipid antibody syndrome. J Rheumatol1995; 22: 768—773.
10.
Kutom AH, Gibbs HRMyocardial infarction due to intracoronary thrombi without significant coronary artery disease in systemic lupus erythematosus. Chest1991; 100: 571—572.
11.
Garcia-Rubira JC, Garcia-Martinez JT, Cruz JMThrombolytic therapy for a patient with systemic lupus erythematosus and acute myocardial infarction . Int J Cardiol1990; 29: 243—244.
12.
Asherson RA , Mackay IR, Harris ENMyocardial infarction in a young man with systemic lupus erythematosus, deep vein thrombosis, and antibodies to phospholipid . Br Heart J1986; 56: 190—193.
13.
Asherson RA , Harris N., Gharavi A.Myocardial infarction in systemic lupus erythematosus and `lupus-like' disease. Arthritis Rheum1986; 29: 1292—1293.
14.
Asherson RA , Khamashta MA, Baguley E. et al. Myocardial infarction and antiphospholipid antibodies in SLE and related disorders. Q J Med1989; 73: 1103—1115.
15.
Shalev Y., Green L., Pollack A. et al. Myocardial infarction with central retinal artery occlusion in a patient with antinuclear antibody-negative systemic lupus erythematosus . Arthritis Rheum1985; 28: 1185—1187.
16.
Takayanagi K., Nakamura Y., Kishimoto M. et al. Cardiac rupture following acute myocardial infarction in systemic lupus erythematosus: case report. Angiology1990; 41: 662—666.
17.
Korbet SM, Schawartz MM, Lewis EJImmune complex deposition and coronary vasculitis in systemic lupus erythematosus. Report of two cases. Am J Med1984; 77: 141—146.
18.
Fearon WF, Cooke JPAcute myocardial infarction in a young woman with systemic lupus erythematosus . Vasc Med1996; 1: 19—23.
19.
Wilson VE, Eck SL, Bates EREvaluation and treatment of acute myocardial infarction complicating systemic lupus erythematosus. Chest1992; 101: 420—424.
20.
Caracciolo AE , Marcu CB, Ghantous A. et al. Coronary vasculitis with acute myocardial infarction in a young woman with systemic lupus erythematosus. J Clin Rheumatol2004; 10: 66—68.
21.
Astorri E., Pattoneri P., Arisi A.Coronary artery disease in young patients with systemic lupus erythematosus: two case reports. Ital Heart J2003; 4: 880—883.
22.
Matayoshi AH, Dhond MR, Laslett LJMultiple coronary aneurysms in a case of systemic lupus erythematosus. Chest1999; 116: 1116—1118.
23.
Park CW, Shin YS, Kim SM et al. Papillary muscle rupture complicating inferior myocardial infarction in a young woman with systemic lupus erythematosus and antiphospholipid syndrome . Nephrol Dial Transplant1998; 13: 3202—3204.
24.
Nobrega TP, Klodas E., Breen JF et al. Giant coronary artery aneurysms and myocardial infarction in a patient with systemic lupus erythematosus. Cathet Cardiovasc Diagn1996; 39: 75—79.
25.
Przybojewski JZ, Botha D., Klopper JF et al. Systemic lupus erythematosus with coronary vasculitis and massive myocardial infarction. A case report. S Afr Med J1986; 69: 765—768.
Rhew EY, Ramsey-Goldman R.Premature atherosclerotic disease in systemic lupus erythematosus — role of inflammatory mechanisms. Autoimmun Rev2006; 5: 101—105.
28.
Galindo M., Chung L., Crockett SD et al. Coronary artery disease in patients with systemic lupus erythematosus . Nat Clin Pract Rheumatol2005; 1: 55—59.
29.
Mattu A., Petrini J., Swencki S. et al. Premature atherosclerosis and acute coronary syndrome in systemic lupus erythematosus. Am J Emerg Med2005; 23: 696—703.
30.
Takegoshi T. , Haba T., Hirai J. et al. A case of hyperLp(a)aemia, associated with systemic lupus erythematosus, suffering from myocardial infarction and cerebral infarction. Jpn J Med1990; 29: 77—84.
31.
Cpc.Sudden death in a 22-year-old woman with lupus erythematosus. Am J Med1987; 82: 65—72.
32.
Spiera H., Rothenberg RRMyocardial infarction in four young patients with SLE. J Rheumatol1983; 10: 464—466.
33.
Willerson JT , Guthrie AM, Buja LMChest pain in a 26-year-old woman with a history of systemic lupus erythematosus and hypertension. Circulation1993; 88: 787—796.
34.
Fukai T., Koyanagi S., Takeshita A. et al. Role of coronary spasm in the pathogenesis of myocardial infarction: study in patients with no significant coronary stenosis. Am Heart J1993; 126: 1305—1311.
35.
Silva Jmp, Oliveira EA, Marino Vsp et al. Premature acute myocardial infarction in a child with nephrotic syndrome. Pediatr Nephrol2002; 17: 169—172.
36.
Jouhikainen T., Pohjola-Sintonen S., Stephansson E.Lupus anticoagulant and cardiac manifestations in systemic lupus erythematosus. Lupus1994; 3: 167.
37.
Osula S., Bell GM, Hornung RSAcute myocardial infarction in young adults: causes and management. Postgrad Med J2002; 78: 27—30.
38.
Peeny WJ, Colvin BT, Brooks N.Myocardial infarction with normal coronary arteries and factor XII deficiency . Br Heart J1985; 53: 230—234.
39.
Meyer T., Schulze F., Grone HJ et al. Simultaneous manifestation of acute myocardial infarction and nephrotic syndrome. Clin Cardiol1998; 21: 519—522.
40.
Nagaoka H., Funakoshi N., Innami R. et al. Left ventricular aneurysm, normal coronary arteries and embolization in a patient with systemic lupus erythematosus. Chest1993; 103: 287—288.
41.
Levine SR, Salowich-Palm L., Sawaya KL et al. IgG anticardiolipin antibody titer >40 GPL and risk of subsequent thrombo-occlusive events and death. A prospective cohort study. Stroke1997; 28: 1660—1665.
42.
Petri M.The lupus anticoagulant is a risk factor for myocardial infarction (but not atherosclerosis): Hopkins Lupus Cohort. Thromb Res2004; 114: 593—595.
43.
Heupler FAJr, Proudfit WL, Razavi M. et al. Ergonovine maleate provocative test for coronary arterial spasm . Am J Cardiol1978; 41: 631—640.
44.
Suwaidi JA, Hamasaki S., Higano ST et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation2000 ; 101: 948—954.
45.
Cooke JP, Singer AH, Tsao PS et al. Anti-atherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest1992; 90: 1168—1172.
46.
De Caterina R, Libby P., Peng HB et al. Nitric oxide decreases cytokineinduced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest1995; 96: 60—68.
47.
Nikpour M., Urowitz MB, Gladman DDPremature atherosclerosis in systemic lupus erythematosus. Rheum Dis Clin N Am2005; 31: 329—354.
48.
Hang LM, Izui S., Dixon FJ(NZWXBXSB) F1 hybrid: a model of acute lupus and coronary vascular disease with myocardial infarction. J Exp Med1981 ; 153: 216—221.
49.
Heibel RH, O'Toole JD, Curtis EL et al. Coronary arteritis in systemic lupus erythematosus. Chest1976; 69: 700—703.
50.
Doherty NE, Siegel RJCardiovascular manifestations of systemic lupus erythematosus. Am Heart J1985; 110: 1257—1265.
51.
Jonsson H., Nived O., Sturfelt G.Outcome in systemic lupus erythematosus: a prospective study of patients from defined population. Medicine1989; 68: 141—150.
52.
Petri M., Perez-Gutthann S., Spence D. et al. Risk factors for coronary artery disease in systemic lupus erythematosus . Am J Med1992; 93: 513—519.
53.
Roman MJ, Shanker BA, Davis A. et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Eng J Med2003; 349: 2399—2406.
54.
AsanumaY., Oeser A., Shintani AK et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med2003; 349: 2407—2415.
55.
Manderson AP , Botto M., Walport MJThe role of complement in the development of systemic lupus erythematosus. Ann Rev Immunol2004; 22: 431—456.
56.
Tsakraklides VG, Blieden LC, Edwards JECoronary atherosclerosis and myocardial infarction associated with systemic lupus erythematosus. Am Heart J1974; 87: 637—641.
